With the analysis among 6,927 patents, we discovered top 451 key players by total patent application. Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Sirna Therapeutics, Inc. are dominant in this area. They take 17.34% of the total patent filing.
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 984
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 120
California, United States
Patent: 97
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 77
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 75
California, United States
Patent: 73
Missouri, United States
Patent: 68
Tokyo-to, Japan
Patent: 59
California, United States
Patent: 58
F. Hoffmann-La Roche Ltd.
With the analysis among 134 patents, we discovered top 29 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Targimmune Therapeutics AG, RNAiSSANCE AG LLC are active in this area.
Institut National de la Santé et de la Recherche Médicale
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 29
Kansas, United States
Patent: 17
Nutcracker Therapeutics, Inc.
California, United States
Patent: 7
Jiangsu Sheng, China
Patent: 7
Nebraska, United States
Patent: 3
Hunan Sheng, China
Patent: 3
Sivec Biotechnologies LLC
Colorado, United States
Patent: 3
With the analysis among related 1,500 patents applied in the last 5 years. We discover 466 most active companies in this area. The fast-growing Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Dicerna Pharmaceuticals, Inc. take 32.40% of patent filing during this period.
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 362
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 91
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 33
Commonwealth Scientific & Industrial Research Organisation
Targimmune Therapeutics AG
Basel-Stadt, Switzerland
Patent: 21
University of Washington Center for Commercialization
Washington, United States
Patent: 15
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 15
Consejo Superior de Investigaciones Científicas
Kansas, United States
Patent: 13
With the analysis among related 1,500 patents in last 5 years, we discover 251 new entrants. AIM ImmunoTech, Inc., Universidad Politécnica de Valencia, University of Coimbra are the most active new entrants in this area.
Universidad Politécnica de Valencia
Valencia, Spain
Patent: 12
Coimbra, Portugal
Patent: 10
Technische Universität München
Centro de Neurociencias e Biologia Celular
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 9
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 8
Nutcracker Therapeutics, Inc.
California, United States
Patent: 7
Fukui-ken, Japan
Patent: 7
Jiangsu Sheng, China
Patent: 7
With the analysis among 2,429 patents, we discovered top 267 universities and scientific research institutions by total patent application. Kobe University, California Institute of Technology, University of Tokyo are dominant in this area. They take 10.91% of the total patent filing.
Kyoto-fu, Japan
Patent: 38
California Institute of Technology
California, United States
Patent: 37
Tokyo-to, Japan
Patent: 32
President & Fellows of Harvard College
Massachusetts, United States
Patent: 31
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 26
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 25
Connecticut, United States
Patent: 23
Thomas Jefferson University
Pennsylvania, United States
Patent: 23
The Johns Hopkins University
The Scripps Research Institute
California, United States
Patent: 22